COGT

Cogent Biosciences Inc
15.17
-0.33 (-2.13%)

Cogent Biosciences Inc. (COGT) Fundamentals

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
SHARE INFORMATION
Market Cap$ 1,083,348,227
Shares Outstanding69,893,434
Float68,312,804
Percent Float97.74%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.87
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions275
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months11,655,286
Institutional Holdings Percent38.4%
Institutional Sold Previous 3 Months14,676,614
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months4,312
Insider Holdings Percent7.3
Insider Sold Previous 3 Months-
Insider Shares Owned5,099,577
TRADING INFO
52 Week High$ 18.07
52 Week Low$ 3.79
52 Week High Change$ 121.11
21 Day Moving Average$ 13.3895
21 Day Extended Moving Average$ 13.6835
50 Day Moving Average$ 12.3124
50 Day Extended Moving Average$ 12.9352
200 Day Moving Average$ 11.3937
200 Day Extended Moving Average$ 11.7134
10 Day Average Volume590,705
20 Day Average Volume712,601
30 Day Average Volume711,342
50 Day Average Volume806,697
Alpha0.044987
Beta1.7370
Standard Deviation0.681309
R20.019234
7 Day Price Change$ 0.75
7 Day Percent Change5.08%
21 Day Price Change$ 3.15
21 Day Percent Change25.51%
30 Day Price Change$ 3.94
30 Day Percent Change34.08%
Month to Date Price Change$ 0.44
Month to Date Percent Change2.92%
Quarter to Date Price Change$ 3.94
Quarter to Date Percent Change34.08%
180 Day Price Change$ 5.00
180 Day Percent Change47.62%
200 Day Price Change$ 4.79
200 Day Percent Change44.72%
Year to Date Price Change$ 3.94
Year to Date Percent Change34.08%

Cogent Biosciences Inc. (COGT) Key Ratios

PROFITABILITY
EBIT Margin-31,649.7%
EBITDA Margin-31,595.2%
Pre-Tax Profit Margin-540.4%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.70
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio12.60
Leverage Ratio1.60
Quick Ratio12.30
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-6.00
Enterprise Value$ 857,799,328
Price to Sales0.00
Price to Free Cash-11.30
PE High Last 5 Years0.00
Price To Book4.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-45.90
Return on Equity-74.73
Return on Capital-70.90

Cogent Biosciences Inc. (COGT) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOAndrews R. Robbins
Emplyoees121
Last AuditUQ
CIK0001622229
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address200 Cambridge Park Drive
Suite 2500
Cambridge, MA 2140
Websitehttps://www.cogentbio.com
Facsimile-
Telephone+1 617 945-5576
Emailstephanie@sternir.com


Your Recent History
NASDAQ
COGT
Cogent Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.